Company Mereo BioPharma Group PLC London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rare Disease Therapies
100.0
%
| 0 | nan % | 12 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01/15/01 |
Founder | 64 | 10/15/10 | |
Charles Sermon
FOU | Founder | 55 | 01/15/01 |
Christine Fox
DFI | Director of Finance/CFO | 43 | 31/21/31 |
Michael Wyzga
CHM | Chairman | 69 | 23/19/23 |
Suba Krishnan
CTO | Chief Tech/Sci/R&D Officer | 59 | 07/20/07 |
John Lewicki
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/20/01 |
Richard Francis
PRN | Corporate Officer/Principal | - | 01/19/01 |
Corporate Officer/Principal | 53 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23/19/23 |
Director/Board Member | - | 10/22/10 | |
Director/Board Member | 59 | 23/19/23 | |
Founder | 64 | 10/15/10 | |
Director/Board Member | 70 | 01/15/01 | |
Pierre Jacquet
BRD | Director/Board Member | 57 | 20/21/20 |
Justin Roberts
BRD | Director/Board Member | - | 10/22/10 |
Annalisa Jenkins
BRD | Director/Board Member | 58 | 10/22/10 |
Jeremy Bender
BRD | Director/Board Member | 52 | 01/20/01 |
Daniel Shames
BRD | Director/Board Member | - | 10/22/10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 643,204,794 | 301,926,833 ( 46.94 %) | 0 | 46.94 % |
Company contact information
Mereo BioPharma Group Plc
1 Cavendish Place 4th Floor
W1G 0QF, London
+44 33 3023 7300
http://www.mereobiopharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |